BioAdvance β Full Portfolio
58 tracked investments Β· listed companies and verified rows first
BiotechNew York, US
Sergio Traversa(Executive Officer, Director)Charles Casamento(Director)Paul Kelly(Director)Maged Shenouda(Director)
Nurse retention platform designed to identify risk up to 12 months in advance.
HealthtechPhiladelphia, US
Joseph Kaupp(Executive Officer, Director)Sean O'Neill(Executive Officer, Director)Steven Powell(Director)Patrick Fitzgerald(Director)Sam Wilson(Executive Officer)
BoardAmy Gallagher(Director)
BiotechHummelstown, US
Stephen C. Rocamboli(Executive Officer, Director)Rifat Pamukcu(Director)Robert Towarnicki(Executive Officer, Director)Roger Sawhney(Director)
BoardTim Van Treuren(Director)John Fucci(Director)
HealthtechNew York, US
Steve Agular(Director)Sean Kearney(Director)Melissa P. Manice(Executive Officer, Director)Daniel Weinstein(Executive Officer, Director)
Concarlo Therapeutics develops cancer therapeutics that target CDK4/6-driven cell proliferation and CDK2-driven resistance, focusing on improving outcomes for cancer patients through novel approaches in p27 biology.
BiotechBrooklyn, US
LisaMarie Casey(President and Manager)Stacy Blain(Founder and CEO)
Eliksa develops regenerative medicine therapies for rare diseases, processing acellular biological products in its own cGMP facility.
BiotechDigital HealthMedical Devices
ENB Therapeutics develops oncology molecules that block the endothelin B receptor (ETBR) to improve immune-based cancer therapies.
BiotechHealthtechNew York, US
Fumitaka Mori(Director)Sumayah Jamal(President, Co-founder & Chief Scientific Officer)Albert Sokol(Executive Officer)Sandy Harm(Chief Operating Officer)Robert Schneider(Co-founder & Chair of Scientific Advisory Board)
BoardBarbara Schilberg(Director)
Hanimune Therapeutics develops food products designed to introduce common allergens into diets to build tolerance, including Lil Mixins for adding allergens to infant diets and Top9Proteins for controlled allergen exposure at any age.
BiotechFoodTechHealthtech
King Of Prussia, US
William Conlan(Executive Officer, Director)Mark McAdoo(Executive Officer, Director)David Tamburri(Director)Mike Kane(Director)
BiotechNew York, US
Nader Halim(Executive Officer, Director)Althea Stillman(Executive Officer, Director)
BoardJonathan Leff(Director)David Greenwald(Director)
BiotechCranbury, US
Wei Wang(Executive Officer, Director)Bo Liang(Executive Officer, Director)Houman Hemmati(Executive Officer, Director)John J Baldwin(Director)Tao Du(Director)
BoardQi Zhu(Director)
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.
BiotechDeep TechHealthtechMedical DevicesBaltimore, US
Allan Doctor(Co-Founder & CSO)inDipanjan Pan(Co-Founder, Chief Technical Officer)inPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)
Keriton offers a software platform for neonatal and pediatric hospital settings that supports safe infant feeding practices, milk management (donor human milk, formula, and parental human milk), and family engagement through features like secure photo sharing, e-journaling, and clinician messaging.
BiotechDigital HealthHealthtechSaaSPhiladelphia, US
Vidur Shailendra Bhatnagar(Manager)
Gene therapy company; recently appointed Bethany Mancilla as Chief Business Officer.
BiotechPhiladelphia, US
Shariff S. Bayoumy(Executive Officer)Brett A. Tounge(Executive Officer, Director)Lawrence C. Kuo(Executive Officer)Michael Serrano-Wu(Director)
BoardBarbara Schilberg(Director)
BiotechSpring House, US
Harry Arader(Director)Rifat Pamukcu(Executive Officer, Director)
BiotechWayne, US
Roy Levitt(Executive Officer, Director)Stephen Tullman(Executive Officer, Director)Paul Barone(Executive Officer, Director)Brian Lortie(Executive Officer, Director)Douglas Gessl(Executive Officer)
BiotechBryn Mawr, US
Martin D. Phillips(Executive Officer, Director)Nicholas W. Lukacs(Director)Frank Marcoux(Director)Alan E. Casnoff(Director)
HealthtechPhiladelphia, US
Michael Zeidlhack(Executive Officer, Director)Marc Tobias(Executive Officer, Director)Naveen Muthu(Director)
New York, US
James Wyman(CFO and Director)Yogendra Jain(Director)Emanuele Musini(CEO and Director)
BiotechGreenwhich, US
Arthur Feldman(Director)Magdalene Cook(Executive Officer, Director)Wendy DiCicco(Ms. DiCicco is the Secretary and Treasurer of the Issuer.)Campbell Murray(Director)Edward J. Benz, Jr.(Director)Thomas Needham(Director)
Ribonova is a biopharmaceutical company discovering and developing novel small-molecule medicines for patients with serious rare diseases.
BiotechMedical Devices
BiotechPhiladelphia, US
Philip Ball(Executive Officer, Director)Damia Tormo Carulla(Director)Justin Vogel(Executive Officer, Director)Francisco Leon(Executive Officer, Director)Robert Goldstein(Director)
BoardPablo Cironi(Director)
Developing ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral beta-lactam/beta-lactamase inhibitor combination for complicated urinary tract infections.
Malvern, US
Vesteck develops medical device technology in the cardiovascular/endovascular space.
HealthtechMedical DevicesWest Chester, US
John Edoga(Director)Rafferty Joseph(Executive Officer, Director)Edward Wulfman(Executive Officer)Kent Stalker(Principal Investigator)JOHN DIEDERICH(Director)THIERRY RICHARD(Director)
Vittoria Biotherapeutics is a clinical-stage company developing next-generation autologous CAR T-cell immunotherapies for oncology and immunology, built on its Senza5 platform that uses CD5 signaling modulation and a 5-day manufacturing process.
BiotechMedical Devices
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.